Act Pharma Limited is engaged in manufacturing of active pharmaceutical ingredients. Due to change in laws and regulations, every company engaged in…

CA Final · Advanced Auditing, Assurance and Professional Ethics · MTP · May 2025
Act Pharma Limited is engaged in manufacturing of active pharmaceutical ingredients. Due to change in laws and regulations, every company engaged in manufacturing in active pharmaceutical ingredients would now require production capacity license which will restrict the production of companies. Management of the company assessed the impact of the change in law over the financial position of company and appropriately disclosed the same in the financial statement. Audit Team of the company evaluated management's disclosure and found it appropriate and sufficient. However, considering the said matter as most important and fundamental to users understanding regarding financial statement the audit team decided to disclose the same in Other Matter Paragraph. You as an Engagement Partner are required to guide the Audit Team with respect to reporting of the said matter in Audit Report.

Suggested Answer and Working Notes:

As per SA 706, “Emphasis of Matter Paragraphs and Other Matter Paragraphs in the Independent Auditor's Report

Topics: Professional Ethics & Liabilities of Auditors, Standard on Auditing (SA)

Open in Interactive Practice Hub · Full Practice Hub · Chapter Weightage · More in this subject

Related Questions in this Topic